Center Management Operations: Administrative Core The Administrative Core, centered at the University of Minnesota will manage, coordinate, and supervise the entire range of Center activities, monitoring progress, ensuring the data are shared securely and ensuring that a strategic plan is carried out effectively and efficiently. The PI (Dr. Patterson) and Administrative Core staff will be responsible for ensuring that appropriate systems are in place to provide for biosafety and security of materials, data, facilities and compliance with U.S., DHHS and NIH laws and regulations. The Administrative core staff will include Dr. Patterson (Pi/Director), Dr Robert Vince (Co-Director), Dr. Herbert Nagasawa (consultant for scientific coordination), Rebbecca Moen (Minnesota Research Services Organization and Office of Clinical Research) and Wanda Lee (Accounting/Administrative Coordination). Dr. Nagasawa, Professor Emeritus of the University of Minnesota and principal inventor of the mercaptopyruvate prodrugs, now resides in Irvine, California, which is close to the U C Irvine and U C San Diego campuses. Therefore, he is geographically ideally situated to coordinate the sharing of research and other information among the research groups. Dr. Nagasawa is in continual contact with Dr. Patterson by telephone, e-mail or fax, and meets twice yearly with him. This will continue. In addition,he will met quarterly with with Drs Boss and Brenner (or more often if needed) and will coordinate the experimental data sharing among the three projects. The scientific personnel of the Administrative core (Drs Patterson, Vince and Nagaswa) will assist in developing a data sharing agreement between the individual institutions involved in the grant (Minnesota, U C Irvine and U C san Diego). This should allow the individual project Pis to publish results jointly or independently in peer reviewed journals and present at scientific conferences in a timely manner as required by the NIH data sharing policy without compromise of sensitive information. Private sharing of sensitive data among the individual projects will be will be handled through a secure server located at the Center for Drug Design and information will be transferred to the server via secure FTP. Additional support is available through the University of Minnesota Office of Clinical Research (OCR). The OCR will assist investigators by supporting Data and Safety Monitoring Boards (DSMB), for clinical trials that require one. The OCR will coordinate scheduling of DSMB meetings, recording of minutes, dissemination of data, committee member identification, DSMB reports, and submission of reports to the IRB and other entities as required. The Office of Clinical Research in the Academic Health Center of The University of Minnesota provides full service clinical research support and will serve in this role for any clinical trials conducted within the proposed projects. Specifically, the Office will provide project management, assistance with IND applications, monitoring of clinical trials for regulatory compliance, and support for any Data and Safety Monitoring Boards necessary.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54NS063718-03
Application #
8130862
Study Section
Special Emphasis Panel (ZNS1)
Project Start
Project End
2012-05-31
Budget Start
2010-06-01
Budget End
2012-05-31
Support Year
3
Fiscal Year
2010
Total Cost
$37,085
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Tsai, Chen S; Mao, Rong W; Tsai, Shirley C et al. (2017) Faraday Waves-Based Integrated Ultrasonic Micro-Droplet Generator and Applications. Micromachines (Basel) 8:
Brenner, Matthew; Azer, Sarah M; Oh, Kyung-Jin et al. (2017) Oral Glycine and Sodium Thiosulfate for Lethal Cyanide Ingestion. J Clin Toxicol 7:
Brenner, M; Benavides, S; Mahon, S B et al. (2014) The vitamin B12 analog cobinamide is an effective hydrogen sulfide antidote in a lethal rabbit model. Clin Toxicol (Phila) 52:490-7
Tsai, C S; Mao, R W; Lin, S K et al. (2014) Faraday instability-based micro droplet ejection for inhalation drug delivery. Technology (Singap World Sci) 2:75
Lee, Jangwoen; Kim, Jae G; Mahon, Sari B et al. (2014) Noninvasive optical cytochrome c oxidase redox state measurements using diffuse optical spectroscopy. J Biomed Opt 19:055001
Nath, Anjali K; Roberts, Lee D; Liu, Yan et al. (2013) Chemical and metabolomic screens identify novel biomarkers and antidotes for cyanide exposure. FASEB J 27:1928-38
Kim, Jae G; Lee, Jangwoen; Mahon, Sari B et al. (2012) Noninvasive monitoring of treatment response in a rabbit cyanide toxicity model reveals differences in brain and muscle metabolism. J Biomed Opt 17:105005
Lee, Sang-Won; Heidary, Andrew E; Yoon, David et al. (2011) Quantification of airway thickness changes in smoke-inhalation injury using in-vivo 3-D endoscopic frequency-domain optical coherence tomography. Biomed Opt Express 2:243-54
Chan, Adriano; Crankshaw, Daune L; Monteil, Alexandre et al. (2011) The combination of cobinamide and sulfanegen is highly effective in mouse models of cyanide poisoning. Clin Toxicol (Phila) 49:366-73
Brenner, Matthew; Kim, Jae G; Lee, Jangwoen et al. (2010) Sulfanegen sodium treatment in a rabbit model of sub-lethal cyanide toxicity. Toxicol Appl Pharmacol 248:269-76

Showing the most recent 10 out of 14 publications